Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Revvity, Inc. Common Stock
(NY:
RVTY
)
101.59
+2.07 (+2.08%)
Official Closing Price
Updated: 7:00 PM EST, Feb 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Revvity, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
3 Unpopular Stocks We Think Twice About
February 05, 2026
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...
Via
StockStory
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026
February 05, 2026
From
Revvity
Via
Business Wire
Revvity Inc (NYSE:RVTY) Beats Q4 Earnings Estimates, Provides In-Line 2026 Guidance
↗
February 02, 2026
Via
Chartmill
Tuesday's pre-market session: top gainers and losers in the S&P500 index
↗
January 13, 2026
Via
Chartmill
What's going on in today's session: S&P500 movers
↗
February 02, 2026
Via
Chartmill
Gapping S&P500 stocks in Monday's session
↗
February 02, 2026
Via
Chartmill
Revvity (RVTY) Q4 2025 Earnings Call Transcript
↗
February 02, 2026
Revvity (RVTY) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
World Trade
Discover the top S&P500 movers in Monday's pre-market session.
↗
February 02, 2026
Via
Chartmill
Revvity’s (NYSE:RVTY) Q4 CY2025 Sales Beat Estimates
February 02, 2026
Life sciences company Revvity (NYSE:RVTY) reported revenue ahead of Wall Streets expectations in Q4 CY2025, with sales up 5.8% year on year to $772.1 million. The company’s full-year revenue guidance...
Via
StockStory
Topics
Earnings
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2025
February 02, 2026
From
Revvity
Via
Business Wire
Revvity (RVTY) Q4 Earnings: What To Expect
January 31, 2026
Life sciences company Revvity (NYSE:RVTY) will be announcing earnings results this Monday before market open. Here’s what you need to know.
Via
StockStory
Topics
Artificial Intelligence
Revvity Board Declares Quarterly Dividend
January 26, 2026
From
Revvity
Via
Business Wire
Revvity Stock Gains On Solid Early Q4 Results, Upbeat Outlook
↗
January 14, 2026
Revvity, Inc. (NYSE: RVTY) stock rose on Tuesday after releasing preliminary expectations for Q4 and FY 2025.
Via
Benzinga
These S&P500 stocks are moving in today's session
↗
January 13, 2026
Via
Chartmill
Stay informed with the top movers within the S&P500 index on Tuesday.
↗
January 13, 2026
Via
Chartmill
Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance
January 12, 2026
From
Revvity
Via
Business Wire
These S&P500 stocks are moving in today's pre-market session
↗
January 12, 2026
Via
Chartmill
Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models
January 09, 2026
From
Revvity
Via
Business Wire
3 Cash-Producing Stocks That Concern Us
December 28, 2025
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...
Via
StockStory
Topics
Supply Chain
Q3 Earnings Highlights: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks
December 22, 2025
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Revvity (NYSE:RVTY) and the...
Via
StockStory
Topics
Economy
Revvity to Present at J.P. Morgan Healthcare Conference
December 18, 2025
From
Revvity
Via
Business Wire
3 Reasons RVTY is Risky and 1 Stock to Buy Instead
December 17, 2025
Revvity currently trades at $96.77 per share and has shown little upside over the past six months, posting a middling return of 2.5%. The stock also fell short of the S&P 500’s 13.6% gain during that...
Via
StockStory
Topics
Stocks
Gapping S&P500 stocks in Thursday's session
↗
December 04, 2025
Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
Via
Chartmill
3 Unpopular Stocks with Open Questions
December 03, 2025
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps...
Via
StockStory
Stay updated with the stocks that are on the move in today's after-hours session.
↗
December 03, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
Which S&P500 stocks are moving on Tuesday?
↗
November 25, 2025
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.
Via
Chartmill
Explore the top gainers and losers within the S&P500 index in today's session.
↗
November 25, 2025
Let's delve into the developments on the US markets in the middle of the day on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Via
Chartmill
Option Care Health, DaVita, Revvity, West Pharmaceutical Services, and Bausch + Lomb Shares Skyrocket, What You Need To Know
November 21, 2025
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...
Via
StockStory
Topics
Economy
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Ignore
November 12, 2025
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...
Via
StockStory
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
November 10, 2025
From
Revvity
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.